D-1453-2019 Class II Terminated
FDA drug recall D-1453-2019 was initiated by Zydus Pharmaceuticals USA Inc on May 6, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. The recall status is terminated (terminated Sep 16, 2021). Affected quantity: 40872 25-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2019
- Initiation Date
- May 6, 2019
- Termination Date
- Sep 16, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40872 25-count bottles
Product description
MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Distribution pattern
Nationwide in the USA
Code information
Lots: M713224, M713225, M713226, EXP Nov-19; M814746 EXP Sep-20; M816148 EXP Oct-20; M901600, M901601 EXP Feb-21
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1453-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026